{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:56:22Z","timestamp":1777949782580,"version":"3.51.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.compbiomed.2025.110010","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T06:37:23Z","timestamp":1742711843000},"page":"110010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Semi-empirical Anticoagulation Model (SAM): Dose prediction during warfarin therapy"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0642-6091","authenticated-orcid":false,"given":"Marco","family":"Bontempi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4473-6787","authenticated-orcid":false,"given":"Laura","family":"Borgese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6673-0386","authenticated-orcid":false,"given":"Andrea","family":"Visani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-5969","authenticated-orcid":false,"given":"Gianluca","family":"Giavaresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0606-6038","authenticated-orcid":false,"given":"Benilde","family":"Cosmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cger.2007.01.002","article-title":"Polypharmacy and the geriatric patient","volume":"23","author":"Hayes Bryan","year":"2007","journal-title":"Clin. Geriatr. Med."},{"issue":"Suppl 1","key":"10.1016\/j.compbiomed.2025.110010_b2","first-page":"S113","article-title":"The impact of warfarin on overall survival in cancer patients","volume":"213","author":"Thita","year":"2022","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2215\/CJN.02170218","article-title":"Clinical pharmacology of oral anticoagulants in patients with kidney disease","volume":"14","author":"Nishank","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110010_b4","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/j.1875-9114.2012.01119","article-title":"Drug-drug interactions between warfarin and psychotropics: updated review of the literature","volume":"32","author":"Ashwini","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110010_b5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1302\/2058-5241.3.170018","article-title":"Thromboembolism prophylaxis in orthopaedics: an update","volume":"3","author":"Flevas Dimitrios","year":"2018","journal-title":"EFORT Open Rev."},{"key":"10.1016\/j.compbiomed.2025.110010_b6","series-title":"RIAP report 2019","author":"ISS","year":"2019"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOT.0000000000002484","article-title":"Chronic warfarin anticoagulation in hip fracture patients delays surgery and is associated with increased risk of postoperative complications: A multicenter propensity-score-matched analysis","volume":"37","author":"Levack Ashley","year":"2023","journal-title":"J. Orthop. Trauma."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110010_b8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/ATVBAHA.114.303400","article-title":"Clinical experience with novel oral anticoagulants for thromboprophylaxis after elective hip and knee arthroplasty","volume":"35","author":"Cory","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1345\/aph.1P626","article-title":"Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence guidelines, and challenges remaining","volume":"46","author":"Dager William","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110010_b10","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1185\/03007995.2011.614938","article-title":"Warfarin prophylaxis in patients after total knee or hip arthroplasty \u2013 international normalized ratio patterns and venous thromboembolism","volume":"27","author":"Nordstrom Beth","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110010_b11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/1381612828666220418090928","article-title":"Prophylaxis for venous thromboembolic events in elective total hip and total knee arthroplasty","volume":"28","author":"Theofilos","year":"2022","journal-title":"Curr. Pharm. Des. Mar"},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110010_b12","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1185\/03007995.2011.614938","article-title":"Warfarin prophylaxis in patients after total knee or hip arthroplasty\u2013international normalized ratio patterns and venous thromboembolism","volume":"27","author":"Nordstrom Beth","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.arth.2014.08.032","article-title":"The use of warfarin for DVT prophylaxis following hip and knee arthroplasty: how often are patients within their target INR range?","volume":"30","author":"Denis","year":"2015","journal-title":"J. Arthroplasty"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110010_b14","article-title":"The effect of warfarin use on postoperative outcomes after femoral neck surgery","volume":"12","author":"Jeremy","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13018-019-1199-5","article-title":"The impact of warfarin on operative delay and 1-year mortality in elderly patients with hip fracture: a retrospective observational study.","volume":"14","author":"Gaetano","year":"2019","journal-title":"J. Orthop. Surg. Res."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110010_b16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/annrheumdis-2020-219646","article-title":"Warfarin use and risk of knee and hip replacements","volume":"80","author":"Priyanka","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b17","first-page":"4","article-title":"Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the michigan anticoagulation quality improvement initiative (MAQI2).","volume":"35","author":"Barnes Geoffrey","year":"2013","journal-title":"J. Thromb. Thrombolysis."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110010_b18","first-page":"CD004179","article-title":"Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair","volume":"3","author":"Rachel","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110010_b19","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1378\/chest.07-0273","article-title":"Maintaining therapeutic anticoagulation: the importance of keeping within range","volume":"131","author":"Lane Deirdre","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.33963\/KP.a2023.0050","article-title":"The importance of time in therapeutic range of warfarin for stroke prevention in atrial fibrillation.","volume":"81","author":"Tze-Fan","year":"2023","journal-title":"Kardiol. Pol."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110010_b21","first-page":"556","article-title":"Updated guidelines on outpatient anticoagulation.","volume":"87","author":"Patricia","year":"2013","journal-title":"Am. Fam. Physician"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110010_b22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.thromres.2011.04.012","article-title":"Zeus a new oral anticoagulant therapy dosing algorithm: A cohort study","volume":"128","author":"Cafolla","year":"2011","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110010_b23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0010-4809(69)90030-5","article-title":"Computer-aided long-term anticoagulation therapy","volume":"2","author":"Sheiner","year":"1969","journal-title":"Comput. Biomed. Res."},{"issue":"6442","key":"10.1016\/j.compbiomed.2025.110010_b24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/bmj.289.6442.422","article-title":"Computer assisted management of warfarin treatment","volume":"289","author":"Wilson","year":"1984","journal-title":"Br. Med. J."},{"issue":"6709","key":"10.1016\/j.compbiomed.2025.110010_b25","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bmj.299.6709.1207","article-title":"Computer control of antiocoagulant dose for therapeutic management","volume":"299","author":"Ryan","year":"1989","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02877558","article-title":"A computerized regulation of dosage in oral anticoagulant therapy","volume":"20","author":"Mariani","year":"1990","journal-title":"Ric. Clin. Lab."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.clpt.6100453","article-title":"Prospective study of warfarin dosage requirements based on CYP2c9 and VKORC1 genotypes","volume":"84","author":"Wen","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110010_b28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/clpt.2008.10","article-title":"Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.","volume":"84","author":"Gage","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110010_b29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/clpt.2010.13","article-title":"Integration of genetic, clinical, and INR data to refine warfarin dosing","volume":"87","author":"Lenzini","year":"2010","journal-title":"Clin. Pharmacol. Ther. May"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007691-200302000-00005","article-title":"A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimens","volume":"25","author":"Maria","year":"2003","journal-title":"Ther. Drug Monit."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110010_b31","article-title":"A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children","volume":"15","author":"Anna-Karin","year":"2015","journal-title":"BMC Med. Inform. Decis. Mak."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110010_b32","first-page":"732","article-title":"Applying an artificial neural network to warfarin maintenance dose prediction","volume":"6","author":"Idit","year":"2004","journal-title":"Isr. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2217\/pgs.13.212","article-title":"Prediction of optimal warfarin maintenance dose using advanced artificial neural networks","volume":"15","author":"Enzo","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.compbiomed.2025.110010_b34","first-page":"2022","article-title":"Optimizing warfarin dosing using deep reinforcement learning","volume":"137","author":"Sadjad","year":"2023","journal-title":"J. Biomed. Inf."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b35","first-page":"1","article-title":"Optimizing warfarin dosing for patients with atrial fibrillation using machine learning","volume":"14","author":"Jeremy","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110010_b36","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1538-7836.2008.02959.x","article-title":"An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs medical staff dosage","volume":"6","author":"Poller","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110010_b37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2008-04-149070","article-title":"The largest prospective warfarin-treated cohort supports genetic forecasting","volume":"113","author":"Mia","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110010_b38","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1373\/clinchem.2006.078139","article-title":"Estimation of warfarin maintenance dose based on VKORC1 (-1639 g>a) and CYP2c9 genotypes","volume":"53","author":"Yusheng","year":"2007","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1538-7836.2009.03676.x","article-title":"Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: Do we really need genotyping?","volume":"8","author":"Le Gal","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110010_b40","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.clinthera.2011.09.004","article-title":"Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation","volume":"33","author":"Hyun-Jung","year":"2011","journal-title":"Clin. Ther."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110010_b41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2217\/pgs-2023-0089","article-title":"Warfarin pharmacogenetics in a black zimbabwean cohort: an observational prospective study","volume":"24","author":"Madeleine","year":"2023","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110010_b42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/clpt.2010.37","article-title":"A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2c9 VKORC1, and age.","volume":"87","author":"Hamberg","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b43","first-page":"41","article-title":"Is there a circannual variation in the anticoagulation control of warfarin?","volume":"30","author":"Kannan","year":"2021","journal-title":"Eur. J. Hosp. Pharm."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110010_b44","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1097\/JS9.0000000000000673","article-title":"Exploring the complex relationship between vitamin k gut microbiota, and warfarin variability in cardiac surgery patients","volume":"109","author":"Ling","year":"2023","journal-title":"Int. J. Surg."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/0113892002290846240228061506","article-title":"Safety issues of herb-warfarin interactions","volume":"25","author":"Subhajit","year":"2024","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.compbiomed.2025.110010_b46","article-title":"Semi-empirical anticoagulation model (SAM): INR monitoring during warfarin therap","author":"Marco","year":"2021","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110010_b47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00003088-198611060-00005","article-title":"Clinical pharmacokinetics and pharmacodynamics of warfarin","volume":"11","author":"Holford Nicholas","year":"1986","journal-title":"Clin. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110010_b48","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s11739-016-1553-0","article-title":"The American college of chest physicians treatment guidelines for venous thromboembolism: a review and critical appraisal.","volume":"11","author":"Demetrios","year":"2016","journal-title":"Intern. Emerg. Med."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjmed.2011.08.014","article-title":"Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults","volume":"125","author":"Jacques","year":"2012","journal-title":"Am. J. Med."},{"issue":"2023","key":"10.1016\/j.compbiomed.2025.110010_b50","article-title":"Revealing profile of cancer-educated platelets and their factors to foster immunotherapy development","volume":"40","author":"Drenka","year":"2024","journal-title":"Transl. Oncol."},{"issue":"7\u20138","key":"10.1016\/j.compbiomed.2025.110010_b51","first-page":"337","article-title":"Thrombotic thrombocytopenic purpura: clinico-pathologic characteristics and therapy","volume":"131","author":"Milica","year":"2003","journal-title":"Srp. Arh. Celok. Lek."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110010_b52","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2217\/14622416.8.7.713","article-title":"Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients","volume":"8","author":"Kenji","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.compbiomed.2025.110010_b53","series-title":"Williams Hematology","first-page":"2528","author":"Kenneth","year":"2016"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b54","article-title":"Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from caucasian Asian, and mixed races in thai population","volume":"36","author":"Supatat","year":"2018","journal-title":"Cardiovasc. Ther."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110010_b55","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1248\/bpb1978.10.330","article-title":"Age-dependent change in warfarin distribution volume in rats: effect of change in extracellular water volume","volume":"10","author":"Kato","year":"1987","journal-title":"J. Pharmacobiodyn."},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110010_b56","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Yohei","year":"2017","journal-title":"Blood"},{"issue":"9921","key":"10.1016\/j.compbiomed.2025.110010_b57","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff Christian","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1076029616687849","article-title":"Warfarin interaction with hepatic cytochrome P-450 enzyme-inducing anticonvulsants","volume":"24","author":"Clark Nathan","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110010_b59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jcp.46.4.299","article-title":"Prospective comparative study of computer programs used for management of warfarin","volume":"46","author":"Poller","year":"1993","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110010_b60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(01)00889-0","article-title":"Seasonal control of warfarin therapy.","volume":"111","author":"Gage","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.compbiomed.2025.110010_b61","series-title":"The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","first-page":"299S","author":"Douketis James","year":"2008"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2014.10.015","article-title":"Fever as a risk factor for increased response to vitamin k antagonists: a review of the evidence and potential mechanisms","volume":"135","author":"Self Timothy","year":"2015","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110010_b63","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.amjmed.2003.12.036","article-title":"Role of dietary vitamin k intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols.","volume":"116","author":"Viviane","year":"2004","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110010_b64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1345\/aph.18171","article-title":"INR elevation associated with diarrhea in a patient receiving warfarin","volume":"33","author":"Smith","year":"1999","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1160\/TH03-05-0325","article-title":"Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2c9 genotype.","volume":"91","author":"van Dijk Karen","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.compbiomed.2025.110010_b66","series-title":"Statistical Distributions","author":"Merran","year":"1993"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11613\/BM.2015.015","article-title":"Understanding bland altman analysis","volume":"25","author":"Davide","year":"2015","journal-title":"Biochem. Medica."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110010_b68","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood-2005-03-1108","article-title":"The impact of CYP2c9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen","volume":"106","author":"Sconce Elizabeth","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110010_b69","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11239-010-0459-3","article-title":"Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic","volume":"30","author":"Shaw Paul","year":"2010","journal-title":"J. Thromb. Thrombolysis."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110010_b70","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00228-012-1466-4","article-title":"Warfarin dose prediction in children using pharmacometric bridging\u2013comparison with published pharmacogenetic dosing algorithms.","volume":"69","author":"Anna-Karin","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110010_b71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/FTD.0000000000000177","article-title":"Methods for predicting warfarin dose requirements","volume":"37","author":"Saffian Shamin","year":"2015","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110010_b72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ocl.2016.08.003","article-title":"Preoperative versus postoperative initiation of Warfarin therapy in patients undergoing total hip and knee arthroplasty","volume":"48","author":"Cara","year":"2017","journal-title":"Orthop. Clin. North Am."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110010_b73","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/14740338.2020.1811230","article-title":"An update on hip fracture risk associated with anticoagulant therapy: warfarin versus direct oral anticoagulants","volume":"19","author":"Toshihiro","year":"2020","journal-title":"Expert. Opin. Drug Saf."},{"issue":"August","key":"10.1016\/j.compbiomed.2025.110010_b74","article-title":"A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study","volume":"206","author":"Johnson Stacy","year":"2021","journal-title":"Thromb. Res."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525003610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525003610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:28:39Z","timestamp":1777868919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525003610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":74,"alternative-id":["S0010482525003610"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110010","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semi-empirical Anticoagulation Model (SAM): Dose prediction during warfarin therapy","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110010"}}